Rawizza, H. E., Oladokun, R., Ejeliogu, E., Oguche, S., Ogunbosi, B. O., Agbaji, O., . . . McIlleron, H. M. (2020). Rifabutin pharmacokinetics and safety among TB/HIV-coinfected children receiving lopinavir/ritonavir-containing second-line ART. J Antimicrob Chemother.
Citación estilo ChicagoRawizza, Holly E., et al. "Rifabutin Pharmacokinetics and Safety Among TB/HIV-coinfected Children Receiving Lopinavir/ritonavir-containing Second-line ART." J Antimicrob Chemother 2020.
Cita MLARawizza, Holly E., et al. "Rifabutin Pharmacokinetics and Safety Among TB/HIV-coinfected Children Receiving Lopinavir/ritonavir-containing Second-line ART." J Antimicrob Chemother 2020.
Precaución: Estas citas no son 100% exactas.